Apyx Medical Corporation APYX Payments Of Stock Issuance Costs
Payments Of Stock Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by Apyx Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.
The official record: Apyx Medical Corporation’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apyx Medical Corporation's payments of stock issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apyx Medical Corporation's payments of stock issuance costs?
- Apyx Medical Corporation (APYX) reported payments of stock issuance costs of $62K in Q4 2025.
- How has Apyx Medical Corporation's payments of stock issuance costs changed year-over-year?
- Apyx Medical Corporation's payments of stock issuance costs increased by 10.7% year-over-year, from $56K to $62K.
- What does payments of stock issuance costs mean?
- This metric represents the direct costs incurred in the process of issuing new equity, such as underwriting fees, legal expenses, and registration costs. These costs are typically deducted from the gross proceeds of a stock offering. Tracking these expenses is important for evaluating the efficiency and cost-effectiveness of the company's capital-raising activities.